Skip to main content

Table. 1 Characteristics of Study Population

From: The association of lipid ratios with hyperuricemia in a rural Chinese hypertensive population

Variables*

Total (n = 14,227)

non-HUA (n = 7,907)

HUA (n = 6,320)

P value

Demographics

    

Age, years

63.81 ± 9.36

63.57 ± 8.98

64.10 ± 9.82

< 0.001

Male, %

6716 (47.21)

2624 (33.19)

4092 (64.75)

< 0.001

Current smoking, %

3660 (25.73)

1623 (20.53)

2037 (32.24)

< 0.001

Alcohol use, %

3065 (21.55)

1225 (15.50)

1840 (29.12)

< 0.001

Comorbidity, %

    

Stroke

983 (6.91)

544 (6.88)

439 (6.95)

0.877

CHD

729 (5.12)

364 (4.60)

365 (5.78)

0.002

Diabetes mellitus

2617 (18.39)

1353 (17.11)

1264 (20.00)

< 0.001

Medication use, %

    

Antihypertensive drugs

9223 (64.84)

4968 (62.85)

4255 (67.34)

< 0.001

Glucose-lowering drugs

754 (5.30)

417 (5.27)

337 (5.33)

0.877

Lipid-lowering drugs

506 (3.56)

285 (3.60)

221 (3.50)

0.731

Physical examination

   

BMI, kg/m2

23.61 ± 3.74

23.29 ± 3.82

24.01 ± 3.60

< 0.001

SBP, mmHg

148.39 ± 17.86

149.30 ± 17.38

147.25 ± 18.38

< 0.001

DBP, mmHg

88.93 ± 10.75

88.62 ± 10.39

89.31 ± 11.18

< 0.001

Laboratory results

    

TC, mmol/L

5.16 ± 1.12

5.11 ± 1.08

5.21 ± 1.16

< 0.001

TG, mmol/L

1.81 ± 1.26

1.65 ± 1.06

2.00 ± 1.46

< 0.001

LDL-C, mmol/L

2.98 ± 0.81

2.94 ± 0.79

3.03 ± 0.84

< 0.001

HDL-C, mmol/L

1.57 ± 0.43

1.60 ± 0.43

1.53 ± 0.42

< 0.001

TC/HDL-C ratio

3.44 ± 0.87

3.33 ± 0.81

3.57 ± 0.92

< 0.001

TG/HDL-C ratio

1.32 ± 1.29

1.18 ± 1.06

1.51 ± 1.50

< 0.001

LDL-C/HDL-C ratio

2.01 ± 0.66

1.94 ± 0.62

2.10 ± 0.69

< 0.001

non-HDL-C, mmol/L

3.59 ± 1.00

3.51 ± 0.95

3.68 ± 1.05

< 0.001

Hcy, µmol/L

17.96 ± 11.13

16.29 ± 9.29

20.06 ± 12.77

< 0.001

FBG, mmol/L

6.18 ± 1.61

6.16 ± 1.71

6.21 ± 1.47

0.094

eGFR, ml/min/1.73m2

88.18 ± 20.22

94.49 ± 16.18

80.28 ± 21.93

< 0.001

  1. Abbreviations: CHD, coronary heart disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; Hcy, homocysteine; FBG, fasting blood glucose; eGFR, estimated glomerular filtration rate
  2. *Data are presented as mean ± standard deviation or median (interquartile range) and numbers (percentage) as appropriate
  3. Note: The TC/HDL-C, TG/HDL-C, and LDL-C/HDL-C ratios were calculated as TC, TG, and LDL-C divided by HDL-C, respectively. Non-HDL-C was calculated as HDL-C subtracted from TC.